Anika Therapeutics (ANIK) EPS (Basic) Growth (5y) (2015 - 2025)
Anika Therapeutics (ANIK) EPS (Basic) Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Anika Therapeutics | 286.73 Mn | 248.32 Mn | 21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.50% |
| Sep 30, 2025 | 16.33% |
| Jun 30, 2025 | 15.85% |
| Mar 31, 2025 | -16.62% |
| Dec 31, 2024 | -37.89% |
| Sep 30, 2024 | -37.46% |
| Jun 30, 2024 | -24.59% |
| Mar 31, 2024 | -20.57% |
| Dec 31, 2023 | 13.70% |
| Sep 30, 2023 | -23.19% |
| Jun 30, 2023 | -17.83% |
| Mar 31, 2023 | -9.10% |
| Dec 31, 2022 | 1.58% |
| Sep 30, 2022 | -21.09% |
| Jun 30, 2022 | -17.61% |
| Mar 31, 2022 | -20.43% |
| Dec 31, 2021 | -19.33% |
| Sep 30, 2021 | -42.57% |
| Jun 30, 2021 | -5.02% |
| Mar 31, 2021 | -15.66% |